iSONEP sphingomab: Completed Phase II enrollment

Lpath completed enrollment of about 158 patients in the double-blind, U.S. Phase II Nexus trial comparing monthly intravitreous injections of 4 mg iSONEP alone and 0.5 and 4 mg iSONEP in combination w...